Lerna

Drospirenone, the active ingredient in Lerna, is a combined oral contraceptive presented as a tablet for oral use. It works together with ethinylestradiol to prevent pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus and altering the endometrial lining, and is indicated for women seeking reliable birth control.

GNH USA supplies Lerna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Lerna, a combined oral contraceptive, is used to prevent pregnancy by modulating the hypothalamic‑pituitary‑gonadal axis.

Prevention of pregnancy: provides reliable hormonal birth control for women of childbearing potential. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces heavy menstrual flow. Acne improvement: can lessen moderate acne associated with hormonal fluctuations.

Lerna may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional tension‑type headaches. - Spotting or breakthrough bleeding: irregular light bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Severe hypertension: sudden high blood pressure. - Liver tumor: rare benign hepatic adenoma. - Severe allergic reaction: rash, swelling, or difficulty breathing.

Before prescribing Lerna, clinicians should evaluate individual risk factors and contraindications. - Pregnancy: contraindicated; do not use in women who are or may become pregnant. - Smoking over age 35: avoid due to increased thrombotic risk. - History of thromboembolism: contraindicated because of clotting risk. - Liver disease: use with caution; impaired metabolism may increase side effects. - Migraine with aura: avoid because of elevated stroke risk. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Lerna can interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid): - CYP3A4 inducers (e.g., rifampin, phenytoin): reduce contraceptive efficacy. - St. John’s wort: may decrease hormone levels. - Griseofulvin: can lower oral contraceptive effectiveness. - Certain antifungals (e.g., ketoconazole): may increase hormone concentrations.

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine): may slightly increase plasma hormone levels. - Anticonvulsants (e.g., carbamazepine): may modestly reduce efficacy. - Diuretics (e.g., hydrochlorothiazide): monitor blood pressure and electrolyte balance.